Sugar-blocking medication (Voglibose 0.3mg) to suppress fat accumulation - Shipping and consultation fees included

ボグリボースはα-グルコシダーゼ阻害薬です。

小腸で糖質の吸収をゆるやかにすることで、食後の急激な血糖値の上昇を抑えます。

血糖値の急上昇を抑えることで脂肪として蓄積されにくくなり、ダイエットや体重管理のサポートが期待できます。

食後の眠気や食欲の増加が気になる方にもおすすめのお薬です。

※GLP-1受容体作動薬（マンジャロ・リベルサス等）のような強い食欲抑制作用はありません。

通常、1回1錠（0.3mg）を1日3回、毎食直前に服用してください。

食事を摂らない場合は服用する必要はありません。

飲み忘れた場合は、食後ではなく次回の食事前から通常どおり服用してください。

The displayed price includes consultation and medication fees.

Main Side Effects

・Abdominal bloating
・Increased flatulence
・Diarrhea
・Loose stools
・Abdominal pain

Rarely, serious side effects such as hypoglycemia (when used with other antidiabetic drugs), liver dysfunction, and intestinal obstruction have been reported.

If you experience symptoms such as severe abdominal pain or persistent vomiting, discontinue use and consult a medical institution.

・必ず毎食直前に服用してください。
・食事を抜く場合は服用しないでください。
・効果を得るためには、食事療法や適度な運動をあわせて行うことが大切です。
・他の糖尿病治療薬と併用している方は低血糖に注意してください。

The following individuals should not take this medication:

・Those with an intestinal obstruction or suspected intestinal obstruction.
・Those with severe digestive diseases.
・Those with a history of hypersensitivity to any component of this medication.
・Pregnant or breastfeeding individuals (please consult your doctor).
・Those for whom a doctor has deemed this medication unsuitable.

At our clinic, you can choose between "Standard Delivery (Nekoposu)" or "Takkyubin Compact (+500 yen)" depending on the size of your package and your preferences.Standard Delivery (Nekoposu)Delivered via postal drop-off. You can receive it even if you are not home. Delivery date and time cannot be specified.

Takkyubin Compact (+500 yen)Received in person. You can specify the delivery date and time. Even after shipping, you can change the delivery date and time, or the pickup location such as a sales office or convenience store.For details on delivery methods, please refer to "About Delivery

・Name: Voglibose Tablet
・Generic name: Voglibose
・Manufacturer and distributor: Towa Pharmaceutical Co., Ltd.

<Approved Drugs (Use for Different Purposes)>
This formulation is approved under the Pharmaceuticals and Medical Devices Act for the treatment of diabetes. However, its use for obesity treatment at our clinic is not approved in Japan, and prescriptions from our clinic are not eligible for relief under the Pharmaceutical Adverse Reaction Relief System or similar programs.

<Acquisition Route, etc.>
We procure approved domestic drugs from domestic pharmaceutical wholesalers. Lipid-cutting drugs are procured through appropriate channels in accordance with the processes stipulated by the Ministry of Health, Labour and Welfare.

<Availability of Approved Domestic Drugs>
It is approved in Japan for the treatment of type 2 diabetes.